MMCM
MRNA icon

Murphy & Mullick Capital Management’s Moderna MRNA Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.16K Sell
141
-88
-38% -$4.11K 0.01% 508
2025
Q4 		$6.75K Sell
229
-21
-8% -$571 ﹤0.01% 522
2025
Q3 		$6.46K Sell
250
-69
-22% -$1.93K ﹤0.01% 518
2025
Q2 		$9.43K Sell
319
-259
-45% -$6.82K 0.01% 467
2025
Q1 		$16.4K Hold
578
– – 0.02% 387
2024
Q4 		$24K Buy
+578
New +$27.6K 0.02% 335

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return